Stock Events

Stock Events

Freeline Therapeutics (FRLN) Q2 2023 Earnings

15AugConfirmed

Aug 22

Nov 22

Q4 2022

Q2 2023

-0.51

-0.34

-0.17

0

Details

Expected EPS

N/A

Actual EPS

-0.23

Surprise EPS

-0.23

Surprise Percent

+∞%

Description

Freeline Therapeutics (FRLN) has reported earnings of -0.23 per share for Q2 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.